We are live on
!
Find out more
SFI
Susquehanna Fundamental Investments Portfolio holdings
AUM
$2.67B
1-Year Est. Return
21.74%
This Fund
S&P 500
This Quarter
Est. Return
+1.1%
1 Year Est. Return
+21.74%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.16B
AUM Growth
+$161M
(+2.3%)
Cap. Flow
+$137M
Cap. Flow
% of AUM
1.91%
Top 10 Holdings %
Top 10 Hldgs %
22.62%
Holding
1,265
New
201
Increased
309
Reduced
441
Closed
210
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$44.2M |
| 2 |
Cigna
CI
|
+$42.1M |
| 3 |
Honeywell
HON
|
+$41.2M |
| 4 |
Amgen
AMGN
|
+$41M |
| 5 |
Dell
DELL
|
+$33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$48M |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$37.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$36.3M |
| 4 |
Pfizer
PFE
|
+$34.5M |
| 5 |
SLB Ltd
SLB
|
+$32.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.91% |
| 2 | Industrials | 11.74% |
| 3 | Technology | 11.68% |
| 4 | Healthcare | 11.42% |
| 5 | Consumer Discretionary | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Digital Turbine
APPS
$1.5B
| $114K | ﹤0.01% |
+42,140
| New | +$137K |
|
1027
Omeros
OMER
$1.26B
| $113K | ﹤0.01% |
13,764
-136,793
| -91% | -$1.21M |
|
|
CKPT
1028
DELISTED
Checkpoint Therapeutics
CKPT
| $106K | ﹤0.01% |
+26,334
| New | +$87.8K |
|
1029
RE/MAX Holdings
RMAX
$263M
| $101K | ﹤0.01% |
12,094
-7,867
| -39% | -$75K |
|
1030
Xeris Biopharma Holdings
XERS
$1.55B
| $93.8K | ﹤0.01% |
17,087
-2,625
| -13% | -$10.6K |
|
1031
Fate Therapeutics
FATE
$317M
| $93.4K | ﹤0.01% |
118,186
| – | – |
|
1032
Annexon
ANNX
$873M
| $79.2K | ﹤0.01% |
41,011
-78,714
| -66% | -$262K |
|
1033
Phathom Pharmaceuticals
PHAT
$742M
| $71.9K | ﹤0.01% |
+11,473
| New | +$69.7K |
|
1034
Fastly Inc
FSLY
$4.78B
| $69K | ﹤0.01% |
10,900
-248,394
| -96% | -$2.08M |
|
1035
Rayonier Advanced Materials
RYAM
$561M
| $67K | ﹤0.01% |
11,651
-22,732
| -66% | -$160K |
|
|
DADA
1036
DELISTED
Dada Nexus
DADA
| $66.1K | ﹤0.01% |
35,705
-16,690
| -32% | -$28.7K |
|
1037
Erasca
ERAS
$6.25B
| $64.1K | ﹤0.01% |
46,785
-45,996
| -50% | -$78.9K |
|
1038
ARKO Corp
ARKO
$500M
| $60.9K | ﹤0.01% |
15,408
-62,892
| -80% | -$367K |
|
|
ATXS
1039
DELISTED
Astria Therapeutics
ATXS
| $59K | ﹤0.01% |
+11,051
| New | +$77.3K |
|
1040
Vivid Seats
SEAT
$81.6M
| $54.5K | ﹤0.01% |
+921
| New | +$74.1K |
|
1041
Babcock & Wilcox
BW
$1.39B
| $45.4K | ﹤0.01% |
67,566
-81,422
| -55% | -$101K |
|
1042
Aclaris Therapeutics
ACRS
$860M
| $44.9K | ﹤0.01% |
+29,316
| New | +$62.5K |
|
1043
Ribbon Communications
RBBN
$372M
| $43.5K | ﹤0.01% |
11,100
-10,238
| -48% | -$43.1K |
|
1044
Valens Semiconductor
VLN
$202M
| $42K | ﹤0.01% |
+20,607
| New | +$51.2K |
|
1045
ProKidney
PROK
$304M
| $39.2K | ﹤0.01% |
44,707
-7,421
| -14% | -$10.3K |
|
|
OPI
1046
DELISTED
Office Properties Income Trust
OPI
| $36.3K | ﹤0.01% |
79,675
-76,019
| -49% | -$64.9K |
|
|
HTZWW
1047
Hertz Global Holdings Warrants
HTZWW
$101M
| $29.6K | ﹤0.01% |
13,092
| – | – |
|
1048
Accuray
ARAY
$32.9M
| $29K | ﹤0.01% |
16,190
-17,164
| -51% | -$35.9K |
|
|
DDL
1049
Dingdong
DDL
$509M
| $28.9K | ﹤0.01% |
10,694
| – | – |
|
1050
Cardlytics
CDLX
$24.7M
| $26.6K | ﹤0.01% |
1,463
-7,458
| -84% | -$213K |
|
Similar funds
TCAM
VA
MMEA
CCM
LP
LOAMS
SI
WWM
Susquehanna Fundamental Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Susquehanna Fundamental Investments held 1,265 positions worth $7.16B, up 2.3% from $7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Susquehanna Fundamental Investments's Q1 2025 filing shows 201 new, 309 increased, 441 reduced and 210 closed positions. Its largest new stake was Amgen: 138,916 shares worth $43.3M. The largest sale was Philip Morris, an estimated $48M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Technology.
- Susquehanna Fundamental Investments's largest Q1 2025 buy was Amgen: 138,916 shares worth $43.3M.
- Susquehanna Fundamental Investments added most to General Dynamics in Q1 2025, an estimated $44.2M increase.
- Susquehanna Fundamental Investments's biggest Q1 2025 reduction was Philip Morris, cutting an estimated $48M.
- Susquehanna Fundamental Investments fully exited Alphabet (Google) Class A in Q1 2025, selling an estimated $36.3M.
- Susquehanna Fundamental Investments's ten largest holdings make up 23% of its $7.16B portfolio in Q1 2025.
- Susquehanna Fundamental Investments opened 201 new positions and closed 210 in Q1 2025.
- Susquehanna Fundamental Investments's portfolio value rose 2.3% quarter-over-quarter to $7.16B.
Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.